ConductScience.org, home

Trial · NCT03695705

Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis

NCT03695705, Phase 3, Completed, Post Graduate Institute of Medical Education and Research, Chandigarh

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis. Trials, record NCT03695705. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03695705

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis
NCT number
NCT03695705
Status
Completed
Phases
Phase 3
Enrollment
142 participants, actual
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions
Cirrhosis, Liver
Interventions
Rifaximin 550 mg twice a day and Norfloxacin 400 mg once a day
First posted
2018-10-04
Last updated
2018-10-04

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence SBP in patients on Rifaximin prophylaxis compared to Norfloxacin6 monthsIncidence of development of SBP in patients with(Secondary prophylaxis) or without(Primary prophylaxis) in patients on Rifaximin compared to norfloxacin
SecondaryIncidence of hepatic encephalopathy6 monthsIncidence of development of hepatic encephalopathy in patients on Rifaximin prophylaxis compared to Norfloxacin prophylaxis
SecondaryIncidence of overall mortality6 monthsIncidence of mortality in patients on Rifaximin prophylaxis compared to Norfloxacin prophylaxis
SecondaryIncidence of development of sepsis6 monthsIncidence of development of sepsis in patients on Rifaximin prophylaxis compared to Norfloxacin prophylaxis

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
35535057DERIVEDPubMed
37467180DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03695705

GET https://conductscience.org/api/trials/v1/NCT03695705/registered